Harvest Group Wealth Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-22	Closed	-$1K	–	767
2019 Q4	$1K	Buy	+22	New	+$1K	﹤0.01%	799
2019 Q3	–	Sell	-35	Closed	-$2K	–	1079
2019 Q2	$2K	Hold	35	–	–	﹤0.01%	559
2019 Q1	$3K	Buy	+35	New	+$3K	﹤0.01%	510